Use of turbidimetric growth curves for early determination of antifungal drug resistance of filamentous fungi

Journal of Clinical Microbiology

Volumn 41, Issue 10, 2003, Pages 4718-4725

  Meletiadis, Joseph ^a   Te Dorsthorst, Debbie T A ^a,b   Verweij, Paul E ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b CANISIUS WILHELMINA HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; ITRACONAZOLE; TERBINAFINE;

ARTICLE; ASPERGILLUS FLAVUS; ASPERGILLUS FUMIGATUS; CONCENTRATION RESPONSE; DRUG CONCENTRATION; DRUG RESISTANCE; FILAMENTOUS FUNGUS; FUNGAL STRAIN; FUNGUS; FUNGUS GROWTH; GROWTH CURVE; INCUBATION TIME; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; OPTICAL DENSITY; PILOT STUDY; PRIORITY JOURNAL; REFERENCE VALUE; RHIZOPUS ORYZAE; SCEDOSPORIUM; SCEDOSPORIUM PROLIFICANS; STRAIN DIFFERENCE; TURBIDIMETRY;

ANTIFUNGAL AGENTS; DRUG RESISTANCE, FUNGAL; FUNGI; HUMANS; MICROBIAL SENSITIVITY TESTS; NEPHELOMETRY AND TURBIDIMETRY; SPECTROPHOTOMETRY;

ASPERGILLUS; ASPERGILLUS FLAVUS; ASPERGILLUS FUMIGATUS; FUNGI; RHIZOPUS; RHIZOPUS ORYZAE; SCEDOSPORIUM PROLIFICANS;

EID: 0141992945     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.41.10.4718-4725.2003     Document Type: Article

References (37)

1. Balajee, S. A., and K. A. Marr. 2002. Conidial viability assay for rapid susceptibility testing of Aspergillus species. J. Clin. Microbiol. 40:2741-2745.
2. Caillot, D., L. Mannone, B. Cuisenier, and J. F. Couaillier. 2001. Role of early diagnosis and aggressive surgery in the management of invasive pulmonary aspergillosis in neutropenic patients. Clin. Microbiol. Infect. 7:54-61.
3. Chang, H. C., J. J. Chang, A. H. Huang, and T. C. Chang. 2000. Evaluation of a capacitance method for direct antifungal susceptibility testing of yeasts in positive blood cultures. J. Clin. Microbiol. 38:971-976.
4. Dannaoui, E., E. Borel, M. F. Monier, M. A. Piens, S. Picot, and F. Persat. 2001. Acquired itraconazole resistance in Aspergillus fumigatus. J. Antimicrob. Chemother. 47:333-340.
5. Dannaoui, E., J. Meletiadis, J. W. Mouton, J. F. Meis, and P. E. Verweij. 2003. In vitro susceptibilities of zygomycetes to conventional and new antifungals. J. Antimicrob. Chemother. 51:45-52.
6. Dannaoui, E., F. Persat, M. F. Monier, E. Borel, M. A. Piens, and S. Picot. 1999. Use of spectrophotometric reading for in vitro antifungal susceptibility testing of Aspergillus spp. Can. J. Microbiol. 45:871-874.
7. Denning, D. W. 1996. Therapeutic outcome in invasive aspergillosis. Clin. Infect. Dis. 23:608-615.
8. Denning, D. W., S. A. Radford, K. L. Oakley, L. Hall, E. M. Johnson, and D. W. Warnock. 1997. Correlation between in-vitro susceptibility testing to itraconazole and in-vivo outcome of Aspergillus fumigatus infection. J. Antimicrob. Chemother. 40:401-414.
9. Denning, D. W., and D. A. Stevens. 1990. Antifungal and surgical treatment of invasive aspergillosis: review of 2,121 published cases. Rev. Infect. Dis. 12:1147-1201. (Erratum, 13:345, 1991.)
10. Denning, D. W., K. Venkateswarlu, K. L. Oakley, M. J. Anderson, N. J. Manning, D. A. Stevens, D. W. Warnock, and S. L. Kelly. 1997. Itraconazole resistance in Aspergillus fumigatus. Antimicrob. Agents Chemother. 41:1364-1368.
11. Espinel-Ingroff, A. 2001. In vitro fungicidal activities of voriconazole, itraconazole, and amphotericin B against opportunistic moniliaceous and dematiaceous fungi. J. Clin. Microbiol. 39:954-958.
12. Espinel-Ingroff, A., and T. M. Kerkering. 1991. Spectrophotometric method of inoculum preparation for the in vitro susceptibility testing of filamentous fungi. J. Clin. Microbiol. 29:393-394.
13. Garrigues, J. C., G. Cadet de Fontenay, M. D. Linas, M. Lagente, and J. P. Seguela. 1994. New in vitro assay based on glucose consumption for determining intraconazole [sic] and amphotericin B activities against Aspergillus fumigatus. Antimicrob. Agents Chemother. 38:2857-2862.
14. Gehrt, A., J. Peter, P. A. Pizzo, and T. J. Walsh. 1995. Effect of increasing inoculum sizes of pathogenic filamentous fungi on MICs of antifungal agents by broth microdilution method. J. Clin. Microbiol. 33:1302-1307.
15. Ghannoum, M. A., J. H. Rex, and J. N. Galgiani. 1996. Susceptibility testing of fungi: current status of correlation of in vitro data with clinical outcome. J. Clin. Microbiol. 34:489-495.
16. Kontoyiannis, D. P., and R. E. Lewis. 2002. Antifungal drug resistance of pathogenic fungi. Lancet 359:1135-1144.
17. Kurtz, M. B., I. B. Heath, J. Marrinan, S. Dreikorn, J. Onishi, and C. Douglas. 1994. Morphological effects of lipopeptides against Aspergillus fumigatus correlate with activities against (1,3)-β-D-glucan synthase. Antimicrob. Agents Chemother. 38:1480-1489.
18. Lass-Florl, C., M. Nagl, C. Speth, H. Ulmer, M. P. Dierich, and R. Wurzner. 2001. Studies of in vitro activities of voriconazole and itraconazole against Aspergillus hyphae using viability staining. Antimicrob. Agents Chemother. 45:124-128.
19. Marr, K. A., R. A. Carter, F. Crippa, A. Wald, and L. Corey. 2002. Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clin. Infect. Dis. 34:909-917.
20. Meletiadis, J., J. F. Meis, J. W. Mouton, J. P. Donnelly, and P. E. Verweij. 2000. Comparison of NCCLS and 3-(4,5-dimethyl-2-thiazyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) methods of in vitro susceptibility testing of filamentous fungi and development of a new simplified method. J. Clin. Microbiol. 38:2949-2954.
21. Meletiadis, J., J. F. Meis, J. W. Mouton, J. L. Rodriquez-Tudela, J. P. Donnelly, and P. E. Verweij. 2002. In vitro activities of new and conventional antifungal agents against clinical Scedosporium isolates. Antimicrob. Agents Chemother. 46:62-68.
22. Meletiadis, J., J. F. Meis, J. W. Mouton, and P. E. Verweij. 2001. Analysis of growth characteristics of filamentous fungi in different nutrient media. J. Clin. Microbiol. 39:478-484.
23. Meletiadis, J., J. W. Mouton, J. F. Meis, B. A. Bouman, J. P. Donnelly, and P. E. Verweij. 2001. Colorimetric assay for antifungal susceptibility testing of Aspergillus species. J. Clin. Microbiol. 39:3402-3408.
24. Meletiadis, J., J. W. Mouton, J. F. Meis, B. A. Bouman, P. J. Donnelly, and P. E. Verweij. 2001. Comparison of spectrophotometric and visual readings of NCCLS method and evaluation of a colorimetric method based on reduction of a soluble tetrazolium salt, 2,3-bis{2-methoxy-4-nitro-5-[(sulfenylamino) carbonyl]-2H-tetrazolium-hydroxide}, for antifungal susceptibility testing of Aspergillus species. J. Clin. Microbiol. 39:4256-4263.
25. Meletiadis, J., J. W. Mouton, J. F. Meis, B. A. Bouman, and P. E. Verweij. 2002. Comparison of the Etest and the sensititre colorimetric methods with the NCCLS proposed standard for antifungal susceptibility testing of Aspergillus species. J. Clin. Microbiol. 40:2876-2885.
26. Merz, W. G., D. Fay, B. Thumar, and D. Dixon. 1984. Susceptibility testing of filamentous fungi to amphotericin B by a rapid radiometric method. J. Clin. Microbiol. 19:54-56.
27. Meyers, J. D. 1990. Fungal infections in bone marrow transplant patients. Semin. Oncol. 17:10-13.
28. Moore, C. B., N. Sayers, J. Mosquera, J. Slaven, and D. W. Denning. 2000. Antifungal drug resistance in Aspergillus. J. Infect. 41:203-220.
29. NCCLS. 1998. Reference method for broth dilution antifungal susceptibility testing of conidium-forming filamentous fungi, proposed standard. Document M-38P. National Committee for Clinical Laboratory Standards, Wayne, Pa.
30. Patterson, T. F., W. R. Kirkpatrick, M. White, J. W. Hiemenz, J. R. Wingard, B. Dupont, M. G. Rinaldi, D. A. Stevens, and J. R. Graybill. 2000. Invasive aspergillosis. Disease spectrum, treatment practices, and outcomes. I3 Aspergillus Study Group Medicine (Baltimore). 79:250-260.
31. Petrikkou, E., J. L. Rodriguez-Tudela, M. Cuenca-Estrella, A. Gomez, A. Molleja, and E. Mellado. 2001. Inoculum standardization for antifungal susceptibility testing of filamentous fungi pathogenic for humans. J. Clin. Microbiol. 39:1345-1347.
32. Rex, J. H., M. A. Pfaller, T. J. Walsh, V. Chaturvedi, A. Espinel-Ingroff, M. A. Ghannoum, L. L. Gosey, F. C. Odds, M. G. Rinaldi, D. J. Sheehan, and D. W. Warnock. 2001. Antifungal susceptibility testing: practical aspects and current challenges. Clin. Microbiol. Rev. 14:643-658.
33. Sanders, C. C. 1991. ARTs versus ASTs: where are we going? J. Antimicrob. Chemother. 28:621-623.
34. Stotler, R. W., and M. C. Meyer. 1983. Detection of oxacillin-resistant staphylococci by the AutoMicrobic system. J. Clin. Microbiol. 18:1205-1211.
35. Vitale, R. G., J. W. Mouton, J. Afeltra, J. F. Meis, and P. E. Verweij. 2002. Method for measuring postantifungal effect in Aspergillus species. Antimicrob. Agents Chemother. 46:1960-1965.
36. White, T. C., K. A. Marr, and R. A. Bowden. 1998. Clinical, cellular, and molecular factors that contribute to antifungal drug resistance. Clin. Microbiol. Rev. 11:382-402.
37. Yamada, H., S. Kohno, S. Maesaki, H. Koga, M. Kaku, K. Hara, and H. Tanaka. 1993. Rapid and highly reproducible method for antifungal susceptibility testing of Aspergillus species. J. Clin. Microbiol. 31:1009-1012.